Some researchers constructed a CAR by fusing the extracellular domain of the NKG2D to DAP12 to improve the cytolytic activity of NK cells, highlighting a promising therapeutic potential for treating metastatic colorectal cancer [46]. This evidence concerns the gene KLRK1 and metastatic colorectal cancer.